PlainPharmaWatch

CMS Open Payments · Tool

Aptis Medical, LLC vs Johnson & Johnson Vision Care, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Aptis Medical, LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 9,916, versus 355 for the other company. Its single largest recorded recipient represents 1.0% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Aptis Medical, LLC
HHI 9,916 · top recipient 1.0%
Ranked #136 of 1,838 companies by HHI
Johnson & Johnson Vision Care, Inc.
HHI 355 · top recipient 0.2%
Ranked #1,412 of 1,838 companies by HHI

Payment Overview

Company A

Aptis Medical, LLC

Total Payments
$6.8M
% of Industry
0.0%
Transactions
98
Avg per Transaction
$69.3K
Recipients
95
Avg per Recipient
$71.4K
Payment Types
4
Top Payment Type
Royalty or License
Total Payments
$6.8M
% of Industry
0.0%
Transactions
29,585
Avg per Transaction
$230.76
Recipients
29,358
Avg per Recipient
$232.54
Payment Types
8
Top Payment Type
Compensation for Services Other Than Consulting

Highlighted values indicate the higher figure for each metric.

Total payments compared

Aptis Medical, LLC vs Johnson & Johnson Vision Care, Inc. - total reported payments in CMS Open Payments PY2024

Johnson & Johnson Vision Ca…$6.8MAptis Medical, LLC$6.8M

Payment Types Breakdown

Aptis Medical, LLC

Royalty or License $948.2K

14.0%

Consulting Fee $183.5K

2.7%

Travel and Lodging $48.5K

0.7%

Food and Beverage $18.6K

0.3%

Johnson & Johnson Vision Care, Inc.

Compensation for Services Other Than Consulting $1.4M

20.2%

Food and Beverage $988.8K

14.5%

Travel and Lodging $392.0K

5.7%

Consulting Fee $365.8K

5.4%

Royalty or License $67.5K

1.0%

Education $1.1K

0.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Aptis Medical, LLC

  1. 1

    LUIS SCHEKER

    $1,193,816.79 · 89 txns

  2. 2

    PAUL SIBLEY

    $4,367.68 · 3 txns

  3. 3

    ALEXANDER SHIN

    $501.00 · 2 txns

  4. 4

    MIGUEL PIRELA-CRUZ

    $177.00 · 1 txns

Johnson & Johnson Vision Care, Inc.

  1. 1

    MATTHEW DAVID GELLER

    $538,125.00 · 8 txns

  2. 2

    SOPHIA VISANJI

    $85,114.74 · 139 txns

  3. 3

    JENNIFER E LYERLY

    $85,024.00 · 2 txns

  4. 4

    MELODY D TAVAKOLI

    $80,674.07 · 177 txns

  5. 5

    DENISE M WHITTAM

    $72,560.37 · 112 txns

Summary Comparison

Metric Aptis Medical, LLC Johnson & Johnson Vision Care, Inc.
Total Payments $6.8M $6.8M
% of Industry Total 0.0% 0.0%
Transaction Count 98 29,585
Avg per Transaction $69.3K $230.76
Recipient Count 95 29,358
Avg per Recipient $71.4K $232.54
Payment Type Count 4 8
Top Payment Type Royalty or License Compensation for Services Other Than Consulting

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.